Breaking News
December 10, 2018 - Pregnancy in adolescence linked to increased risks of complications in young mothers
December 10, 2018 - Risk Analysis publishes special issue on communicating about Zika virus
December 10, 2018 - Botox May Help Prevent Post-Op A-Fib
December 10, 2018 - African-American mothers rate boys higher for ADHD
December 10, 2018 - Graphic warning labels cancel out cigarettes’ appeal to young people
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
December 8, 2018 - Scientists overturn odds to make Parkinson’s discovery
December 8, 2018 - Health benefits of producing marula vinegar
December 8, 2018 - Failure of critical cellular energy sensor responsible for CKD progression, study finds
December 8, 2018 - Ethnicity can be reliable indicator of gut microbiota diversity
December 8, 2018 - Safe Sleep for Baby | NIH News in Health
December 8, 2018 - Study looks at ways technology can support nutritional needs of Parkinson’s patients
December 8, 2018 - Infant milk allergy is being overdiagnosed say experts
December 8, 2018 - Graphene may one day be used to test for ALS
December 8, 2018 - Houston Methodist launches real-time website to track flu cases
December 8, 2018 - RedHill Announces Positive Top-Line Results from Confirmatory Phase 3 Study with Talicia for H. pylori Infection
December 8, 2018 - A way to measure obesity and health beyond BMI
December 8, 2018 - New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies
December 8, 2018 - Duke-NUS researchers highlight possible role of bioaerosol sampling in pandemic surveillance
Why Do So Few Docs Have Buprenorphine Waivers?

Why Do So Few Docs Have Buprenorphine Waivers?

image_pdfDownload PDFimage_print

The barriers to obtaining a buprenorphine (Suboxone) waiver in the U.S. are small, but loom large in many physicians’ minds.

Only 46,500 — about 5% of the nation’s doctors — have waivers to prescribe buprenorphine, a medication used to treat opioid addiction. While that number has grown in recent years, it includes psychiatrists and addiction specialists, many of whom don’t practice in rural areas.

But even including those specialties, it’s not enough. “The current number of waivered physicians is not sufficient to ensure access to buprenorphine treatment for all individuals with opioid use disorder, even if every physician were prescribing at the maximum of their waivers,” said Hannah Knudsen, PhD, of the University of Kentucky College of Medicine in Lexington. Knudsen has studied the relationship between the supply of buprenorphine-waivered physicians and prescription opioid mortality.

Pamela Pentin, MD, JD, a family medicine doctor at the University of Washington Medical Center in Seattle, obtained her buprenorphine waiver in 2004. “I saw patients walking into a doctor’s office with chronic pain, being prescribed opioids without regard for any true functional improvement, and then coming in again with opioid addiction as their primary problem,” she recalled.

To Pentin, addiction treatment is part of family care. “We deal with addiction every minute in our practices,” she said. “My obese patients who have diabetes and heart disease are addicted to food. My alcoholic patients with cirrhosis are addicted to alcohol. Why should it be any different for me to treat opioid addiction than it is to treat all the other addictions that family doctors and internists deal with all the time?”

Early in her medical education, Alicia Agnoli, MD, MPH, a family practice doctor at the University of California Davis, did elective training with a buprenorphine-waivered physician. “I saw a whole range of individuals struggling with their drug use,” she said. “And I saw this treatment was really effective. It was not only helping their addiction, but it was engaging them with their primary care doctor and their overall health in a way that was profound.”

Still, many physicians, especially in primary care, are reluctant to get buprenorphine waivers. Agnoli cited a couple of reasons. “There are a few extra hoops to jump through in order to prescribe buprenorphine, and extra [Drug Enforcement Administration] oversight that a lot of physicians don’t want to bother with,” she said.

And there’s the primary care office culture to contend with. “If no one else in their practice is providing this care, a physician might not want to take on the role of champion, of being the sole person taking care of all opioid dependent patients,” she added. “They may not want to deal with fighting with the clinic management. And they probably don’t want to be the first pioneer to figure out how to do drug testing, what’s our relationship with the pharmacy, and who deals with the prior authorizations.”

Despite the growing opioid problem in the U.S., many doctors do not understand addiction treatment. “This is the number one public health problem, yet we continue to approach it as a separate quasi-professional field with no required coursework in the curriculum for medical schools, psychology or social work, despite these professions being the primary point of contact for people with substance use disorders,” said Dessa Bergen-Cico, PhD, of Syracuse University in New York.

Even among doctors who have buprenorphine waivers, utilization is low. In a 2017 survey-based study, Kelly Dunn, MS, PhD, of Johns Hopkins University in Baltimore saw physicians were concerned about not having enough time or resources to help patients with opioid addiction.

“The research suggested that physicians either don’t feel informed enough, or aren’t comfortable with, the idea of prescribing,” she said. “They also said they don’t have the infrastructure to take on many new patients, and have concerns about patients needing additional access to counseling that isn’t generally available in primary care settings. They may not know best way to refer patients or what local resources they have.”

But that may need to change. “Addiction medicine is the newest medical specialty to be recognized, but there are not enough specialists now to combat the opioid epidemic, so primary care providers will be on the front lines whether they want to or not,” said Michael Weaver, MD, of the University of Texas Health Science Center in Houston.

To obtain a buprenorphine waiver, clinicians need to apply to the Substance Abuse and Mental Health Services Administration (SAMHSA). “Physicians need 8 hours of online training which covers pharmacology, the induction process for the drug, and information about best practices,” Pentin explained. Training is free through the Provider’s Clinical Support System for Medication-Assisted Treatment (PCSS-MAT) and qualifies for CME, she added.

Demystifying addiction treatment goes a long way, Agnoli observed.

“We are in a culture shift; addiction treatment has not historically been part of primary care practice,” she said. “Like with any culture change, we see greater gains in newer generations of physicians. Normalizing this in the training phase stands to produce more willing and capable primary care doctors.”

2018-02-14T17:00:00-0500

Tagged with:

About author

Related Articles